- Home
- ARWR vs CALX Comparison
ARWR vs CALX Comparison
Compare ARWR & CALX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- CALX
- Stock Information
- Founded
- ARWR 2003
- CALX 1999
- Country
- ARWR United States
- CALX United States
- Employees
- ARWR N/A
- CALX N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- CALX Telecommunications Equipment
- Sector
- ARWR Health Care
- CALX Consumer Discretionary
- Exchange
- ARWR Nasdaq
- CALX Nasdaq
- Market Cap
- ARWR 2.4B
- CALX 2.5B
- IPO Year
- ARWR 1993
- CALX 2010
- Fundamental
- Price
- ARWR $19.56
- CALX $37.89
- Analyst Decision
- ARWR Buy
- CALX Strong Buy
- Analyst Count
- ARWR 11
- CALX 6
- Target Price
- ARWR $43.33
- CALX $42.50
- AVG Volume (30 Days)
- ARWR 1.5M
- CALX 441.2K
- Earning Date
- ARWR 02-04-2025
- CALX 01-29-2025
- Dividend Yield
- ARWR N/A
- CALX N/A
- EPS Growth
- ARWR N/A
- CALX N/A
- EPS
- ARWR N/A
- CALX N/A
- Revenue
- ARWR $3,551,000.00
- CALX $890,128,000.00
- Revenue This Year
- ARWR $3,402.96
- CALX N/A
- Revenue Next Year
- ARWR $123.96
- CALX $3.13
- P/E Ratio
- ARWR N/A
- CALX N/A
- Revenue Growth
- ARWR N/A
- CALX N/A
- 52 Week Low
- ARWR $17.05
- CALX $26.76
- 52 Week High
- ARWR $36.72
- CALX $45.15
- Technical
- Relative Strength Index (RSI)
- ARWR 47.89
- CALX 61.35
- Support Level
- ARWR $17.75
- CALX $37.09
- Resistance Level
- ARWR $19.19
- CALX $38.66
- Average True Range (ATR)
- ARWR 1.04
- CALX 1.30
- MACD
- ARWR 0.04
- CALX 0.19
- Stochastic Oscillator
- ARWR 59.74
- CALX 84.35
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting hepatitis B, Alpha-1 Antitrypsin Deficiency, thrombosis and angioedema, clear-cell and renal cell carcinoma, and cardiovascular disease.
About CALX Calix Inc
Calix Inc develops, market and sell Calix cloud, systems and software platforms to enable service providers of all types and sizes to innovate and transform. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.